35 For instance, metabolic-bariatric surgery is covered by more than 90% of US private insurers for patients meeting criteria, 35 whereas endoscopic therapies are generally not covered by insurance and may require full out-of-pocket payment
In such cases, the appetite-suppressing effects of GLP-1RAs could potentially exacerbate behaviors like dietary restriction and dietary restraint, two behavioral patterns that help sustain eating disorder psychopathology, thus complicating treatment for these disorders
It behaves like a very effective fat-loss tool with the same lean-mass caveat every rapid weight-loss intervention carries
[3] A 2026 systematic review in The BMJ puts rebound into a broader frame: after stopping weight management medications, average regain was estimated at roughly 0.4 kg per month , with faster regain after newer incretin drugs, and cardiometabolic markers projected to return toward baseline within roughly 1.4 years after stopping
Send the prescription to the pharmacy with: An E66 obesity diagnosis code The exact note: SEND TO BRIDGE FOR WEIGHT MANAGEMENT This is important
